US Bancorp

SEC CIK: 0000036104
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overview All 13F holders of CRVS Full Q2 2026 holdings

Shares (Q2 2026): 166
Value: $2.48K
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2022

Holdings of CRVS by US Bancorp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	166	$2.48K	<0.1%	−937−85.0%	Reduced	Holders
Q1 2026	1,103	$16.1K	<0.1%	+1,103	New	Holders
Q2 2022	0	$0	0.0%	−5,153−100.0%	Sold out	Holders
Q1 2022	5,153	$8.00K	<0.1%	+5,153	New	Holders